Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)?
Find out if you qualify to participate in a clinical trial of an investigational therapy designed to activate the immune system and enable it to fight cancer throughout the body.
Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)?
Find out if you qualify to participate in a clinical trial of an investigational therapy designed to activate the immune system and enable it to fight cancer throughout the body.
LEGION-100 Clinical Trial
This clinical trial is studying an investigational therapy called SYNC-T Therapy SV-102. It is a combination therapy that freezes a portion of a tumor and then infuses a drug directly into the tumor. The therapy is designed to activate the immune system and enable it to fight cancer throughout the body.
